Sign in

CIK 0001398733

  • Non-accelerated filer
  • Smaller reporting company

Aquestive Therapeutics, Inc.

Sign in to watch
Ticker
AQST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208623253
Phone
+1 908-941-1900
Business address
184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
Former names
MonoSol Rx, Inc.
  1. 4 Shares withheld for taxes Chief Innovation/Tech Officer gave up 145 shares (to pay taxes)
  2. 4 Shares withheld for taxes CEO and President gave up 150 shares (to pay taxes)
  3. 4 Derivatives Options or other derivatives
  4. 4 Shares withheld for taxes CEO and President gave up 6,676 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Innovation/Tech Officer gave up 6,460 shares (to pay taxes)
  6. 4 Open-market buy SVP-Chief Operating Officer bought 2,000 shares at $3.99 ($7,980)
  7. 4 Open-market buy Director bought 22,971 shares at an average $3.79 ($86,977)
  8. 4 Open-market buy CEO and President bought 8,000 shares at an average $3.87 ($30,987)
  9. 4 Open-market buy SVP-HR and Org. Development bought 1,000 shares at $3.99 ($3,990)
  10. 4 Open-market buy SVP, General Counsel bought 10,000 shares at $4.07 ($40,747)
  11. 4 Open-market buy SVP-Bus. Process & Info. Tech. bought 600 shares at $3.81 ($2,286)
  12. 4 Shares withheld for taxes CEO and President gave up 154 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Innovation/Tech Officer gave up 149 shares (to pay taxes)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Shares withheld for taxes Chief Innovation/Tech Officer gave up 6,591 shares (to pay taxes)

Page 13 of 17 · 326 filings